Volume 20, Number 4—April 2014
Research
High Rates of Antimicrobial Drug Resistance Gene Acquisition after International Travel, the Netherlands
Table 2
Characteristics of 122 travelers observed for rates of antimicrobial resistance gene acquisition after international travel, the Netherlands, 2010–2012*
Characteristic | No. (%) |
---|---|
Sex | |
M | 51 (41.8) |
F | 71 (58.2) |
Clinical finding | |
Traveler’s diarrhea | 45 (36.9) |
Antimicrobial drug use | 15 (12.3) |
Region visited | |
Southeast Asia | 28 (23.0) |
Indian subcontinent | 31 (25.4) |
Northern Africa | 16 (13.1) |
Southern Africa | 17 (13.9) |
Southern Europe | 6 (4.9) |
Central America | 4 (3.3) |
South America | 6 (4.9) |
Other/multiple | 7 (5.7) |
*Median age, y (range) of travelers was 42.7 (18–72) and median travel duration, (range) was 21.0 (5-20) months. Countries in respective regions are as follows: Southeast Asia (Indonesia, Philippines, Malaysia, Myanmar, Cambodia, Thailand, Vietnam), Indian subcontinent (India, Nepal, Sri Lanka), northern Africa (Canary Islands, Egypt, Gambia, Ghana, Togo, Morocco, Senegal, Uganda), southern Africa (Namibia, Kenya, Tanzania, Zanzibar, Mauritius, South Africa), Central America (Panama, Costa Rica, Mexico), South America (Argentine, Bolivia, Brazil, Columbia, Peru, Suriname), southern Europe (Croatia, Spain, Turkey), other (Australia, Fiji, New Zealand, Oman).
*These authors contributed equally to this article and are co–first authors.